Strangles vaccine within reach for horsesFebruary 12, 2018Scientists from the Animal Health Trust (AHT), the Swedish University of Agricultural Sciences, the Karolinska Institute, and Intervacc AB, have developed a new protein-based vaccine to protect horses from strangles. Strangles, caused by Streptococcus equi bacteria, leads to large pus-filled abscesses in horses' throat and neck. The research was recently published in Vaccine. " … Our Strangvac vaccine protected over 80 percent of horses from this dreadful disease," said Jan-Ingmar Flock, Ph.D., CEO of Intervacc AB, the company that produced the vaccine. "Strangles is a scourge of the equine world and the development of Strangvac has the potential to prevent many thousands of horses from falling ill each year." "Strangvac is an extremely exciting vaccine," said Dr. Andrew Waller, head of bacteriology at AHT. "The vaccine was designed using information from sequencing the DNA of Streptococcus equi and highlights the potential that the genome-era heralds for improving the health of animals and people. Improving the health of horses is a core aim of the Animal Health Trust and we are proud to have helped make this vaccine a reality towards finally breaking the hold this disease currently has on our …
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
